RedHill Biopharma reported $4.27M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Cara Therapeutics USD 14.5M 6.44M Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 95.35M 7.38M Mar/2026
Cronos Group USD 1.07B 4.99M Jun/2026
RedHill Biopharma USD 4.27M 8.68M Dec/2025